Naynay, Junryl M.
HRN: 22-35-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2022
CEFTRIAXONE 1G (VIAL)
12/22/2022
12/28/2022
IV
2g
Once Daily
Acute Pyelonephritis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes